Mortality and the Use of Antithrombotic Therapies Among Nursing Home Residents with COVID-19.

ABSTRACT:

Background/objectives

Nursing home (NH) residents are a vulnerable population, susceptible to respiratory disease outbreaks such as coronavirus disease 2019 (COVID-19). Poor outcome in COVID-19 is at least partly attributed to hypercoagulability, resulting in a high incidence of thromboembolic complications. It is unknown whether commonly used antithrombotic therapies may protect the vulnerable NH population with COVID-19 against mortality. This study aimed to investigate whether the use of oral antithrombotic therapy (OAT) was associated with a lower mortality in NH residents with COVID-19.

Design

A retrospective case series.

Setting

Fourteen NH facilities from the NH organization Envida, Maastricht, the Netherlands PARTICIPANTS: A total of 101 NH residents with COVI

SUBMITTER: Brouns SH 

PROVIDER: S-EPMC7361386 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature